SEC Form 4 · accession 0001493152-26-037352
TAKEDA PHARMACEUTICAL CO LTD · TAK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elaine Mary Shannon
Officer — Pres., Global Supply & Quality
Period of report
Aug 11, 2026
Accepted (ET)
Aug 12, 2026 · 4:10 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001395064
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Aug 11, 2026 | S | 20,363 | $17.55 | D | 67,311 | D |
Table II — derivative securities
No Table II lines on this filing.